Clinical Trials Logo

Clinical Trial Summary

Assessment of the digestive tolerability of the PROMITOR® .


Clinical Trial Description

The trial will be multicenter, double-blind, placebo-controlled, randomized with a 4-arm parallel-design. The subjects wil be randomized to one of the four arms, i.e. four doses of investigational product balanced in maltodextrin, given at the doses of 6, 9 or 12 g (corresponding to 4, 6, or 8 g of fibers) twice a day with the meals of the morning and of the evening versus control (maltodextrin, no fibers) over one week of intake.

The total sample size is 40 healthy children from 8 to 12 years old, male and female. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)


Related Conditions & MeSH terms


NCT number NCT02519374
Study type Interventional
Source Nestlé
Contact
Status Completed
Phase N/A
Start date June 2015
Completion date August 2015

See also
  Status Clinical Trial Phase
Completed NCT02530762 - Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary Fiber N/A
Completed NCT02532985 - Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary Fiber N/A
Recruiting NCT01464814 - Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules N/A
Completed NCT02180035 - Treatment With Nutritional Eating Plan and Dietary Fibers in Adult Patients With HIV/AIDS N/A
Completed NCT05603403 - Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms Phase 4
Recruiting NCT02928484 - Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function Phase 1/Phase 2
Completed NCT02677090 - Fiber Tolerability in Children Aged 3-7 Year N/A
Completed NCT00822328 - Fermented Milk Drink on Human Intestinal Microflora Phase 2
Completed NCT02253628 - The Acute Effect of Coffee Consumption on Stomach, Self-reported Gastrointestinal Symptoms and Stress. N/A
Completed NCT00251914 - Nexium Dyspepsia/AST Phase 3
Completed NCT00251992 - Nexium Dyspepsia/AST Phase 3
Completed NCT01431482 - Evaluation of the Composition of Human Milk and Health Outcomes in Children
Terminated NCT01675960 - Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children Phase 2
Completed NCT00652834 - Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept® Phase 4
Active, not recruiting NCT00110708 - Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism Phase 2